ARASENS Trial: Should darolutamide now be added to androgen-deprivation therapy and docetaxel in patients with metastatic, hormone-sensitive prostate cancer?

Bibliographic Details
Main Author: Naveen Kumar
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Indian Journal of Urology
Online Access:http://www.indianjurol.com/article.asp?issn=0970-1591;year=2022;volume=38;issue=3;spage=238;epage=239;aulast=Kumar